Skip to content

Supplier News

Lupin gets FDA nod for depression drug

Lupin gets FDA nod for depression drug

Lupin announced on Tuesday that it has received approval from the United States Food and Drug Administration (FDA) to market a generic version of Alvogen’s Fluoxetine Tablets, 60mg. Fluoxetine is indicated in the treatment of major depressive disorders.